
TATA健康(01255)发布截至2025年6月30日止六个月业绩,收入4211.8万港元,同比下降41.8%;公司拥有人应占溢利2059.6万港元,上年同期亏损513万港元;每股基本盈利0.08港元。
期内收入同比减少,主要由于鞋类业务收入减少。集团于报告期间的鞋类业务收入减少主要由于消费者情绪疲软及持续经济不确定性,为中国香港零售业创造充满挑战的环境。
本文地址: http://www.jiaotongmi.com/article/11296.html
文章来源:admin
版权声明:除非特别标注,否则均为本站原创文章,转载时请以链接形式注明文章出处。
2025-11-19admin
2025-11-13admin
2025-11-12admin
2025-11-11admin
2025-11-10admin
2025-11-09admin
2025-11-08admin
2025-11-07admin
2025-11-06admin
2025-11-05admin
2025-09-08admin
2025-09-08admin
2025-09-17admin
2025-09-17admin
2025-09-13admin
2025-09-08admin
2025-09-09admin
2025-09-09admin
2025-09-13admin
2025-09-11admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
扫码二维码
获取最新动态
